SB202494
has no known p38 MAPK inhibitory effects
Also Known As:
4-ethyl-2-(4-methoxyphenyl)-5-(4-pyridyl)-1H-imidazole; SB 202474; SB 202494; SB-202474; SB-202494; SB202474
Networked: 3
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
1. | Liu, Changjiang:
1 article
(01/2018)
|
2. | Yang, Min:
1 article
(01/2018)
|
3. | Zeng, Li:
1 article
(01/2018)
|
4. | Zhang, Pei:
1 article
(01/2018)
|
5. | Hara, A:
1 article
(03/2010)
|
6. | Hayashi, K:
1 article
(03/2010)
|
7. | Hoshino, T:
1 article
(03/2010)
|
8. | Ishii, T:
1 article
(03/2010)
|
9. | Nishimura, B:
1 article
(03/2010)
|
10. | Oikawa, K:
1 article
(03/2010)
|
Related Diseases
Related Drugs and Biologics